Riskpilot← Back to searchSign inGet full accessFARMATEKET AF 2. AUGUST 2012 ApS
APSActiveCVR 34624089Østervold 24Retail sale of pharmaceutical products · NACE 4773Est. 20122 employees
Revenue 2024
DKK -9K
+5% vs 2023
EBITDA margin
100.0%
-5% vs 2023
Equity ratio
-1491.2%
Financial strength
Net profit 2024
DKK 8K
+128% vs 2023
| Revenue | DKK -9K | +5% |
| EBITDA | DKK -9K | -5% |
| Net profit | DKK 8K | +128% |
| Total assets | DKK 79K | +251% |
| Equity | DKK -1,2M | +1% |
| Employees | 2 | — |
Legal name
FARMATEKET AF 2. AUGUST 2012 ApS
CVR number
34624089
Legal form
Anpartsselskab
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. august 2012
Share capital
DKK 80.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive detailhandel, herunder som apoteks håndkøbsudsalg. I det omfang lovningen måtte tillade det, kan apoteket endvidere drive anden apoteksvirksomhed.
Address
Østervold 24
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -7 | -7 | -7 | -8 | -8 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -7 | -7 | -7 | -8 | -8 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -7 | -7 | -7 | -8 | -8 |
| Net financials | -19 | 0 | -29 | -42 | -40 |
| Profit before tax | -26 | -7 | -37 | -50 | -49 |
| Tax | -52 | -41 | -72 | -23 | -56 |
| Net profit | 26 | 34 | 35 | -28 | 8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 52 | 41 | 72 | 23 | 79 |
| Equity | -1.229 | -1.195 | -1.161 | -1.188 | -1.181 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.281 | 1.236 | 1.232 | 1.211 | 1.260 |
| Total debt | 1.281 | 1.236 | 1.232 | 1.211 | 1.260 |
EBITDA margin
-850000.0%
This company
15.8%
Market median
-5379847% vs market
20202024
Equity ratio
-1491.2%
This company
38.2%
Market median
-4004% vs market
20202024
Return on equity
774000.0%
This company
18.4%
Market median
+4206422% vs market
20202024
Net profit margin
774000.0%
This company
8.1%
Market median
+9555456% vs market
20202024
Asset turnover
-0.11×
This company
1.12×
Market median
-110% vs market
20202024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TB Founder | Founder | 2012 |
NJ Management | Management | 2017 |
| Former (1) | ||
BL Management | Management | 2012 – 2017 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VITALIS HOLDING ApS
FARMATEKET AF 2. AUGUST 2012 ApS Board members of FARMATEKET AF 2. AUGUST 2012 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tina Balderlou Jensen | Founder | 0 companies |
| Bjarne Leif Riis Nygaard | Management | 0 companies |
| Naser Jensen | Management | 0 companies |